ACSL4 and cancer: A study using Oncomine and The Cancer Genome Atlas (TCGA) databases together with in vitro clear cell renal cell carcinoma showed that suppression of ACSL4 increased ferroptosis resistance, whereas overexpression of ACSL4 could restore ferroptosis sensitization in cancer cells (Guo 2022).